Biotech news for Thursday, May 21, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Annovis Bio, Inc. ( NASDAQ: ANVS ) on Tuesday said it launched a proposed underwritten public offering of common stock and accompanying warrants to purchase common stock. The company said the shares and warrants will be issued separately but sold together in t…
Relay Therapeutics ( RLAY ) announced an underwritten public offering of $175M in common stock. The company also plans to grant underwriters a 30-day option to purchase up to an additional 15% of the offered shares. All shares in the proposed offering
alexsl Ionis Pharmaceuticals ( IONS ), Alnylam ( ALNY ), and BioMarin Pharmaceutical ( BMRN ) were among the gainers on Tuesday after Citi launched the SMid Cap Biotech group with a bullish view, citing compelling growth and catalyst outlook. In a research not…
Md Saiful Islam Khan Tiziana Life Sciences ( TLSA ) announced on Tuesday that new data from a study for an intranasal version of its lead asset, foralumab, indicated that the drug was well-tolerated for longer in patients with multiple sclerosis, an immune dis…
sitox Stock futures inched lower Tuesday as investors weighed high-yielding Treasury notes against easing Middle East tensions after President Trump paused a planned strike on Iran. Here are some of Tuesday's biggest stock movers: Biggest stock gainers Agilysy…
designer491 UCB ( UCBJY ) announced on Tuesday that its biologic medicine Bimzelx outperformed AbbVie’s ( ABBV ) immunology therapy Skyrizi in a head-to-head trial for psoriatic arthritis, an inflammatory condition affecting both skin and joints. Citing Week 1…